1. Home
  2. TNXP vs MINE Comparison

TNXP vs MINE Comparison

Compare TNXP & MINE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tonix Pharmaceuticals Holding Corp.

TNXP

Tonix Pharmaceuticals Holding Corp.

HOLD

Current Price

$12.74

Market Cap

198.6M

Sector

Health Care

ML Signal

HOLD

MINE

Mayfair Gold Corp. Common Shares

N/A

Current Price

$2.86

Market Cap

211.7M

Sector

Energy

ML Signal

N/A

Company Overview

Basic Information
Metric
TNXP
MINE
Founded
2007
2019
Country
United States
Canada
Employees
N/A
6
Industry
Biotechnology: Pharmaceutical Preparations
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
198.6M
211.7M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
TNXP
MINE
Price
$12.74
$2.86
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
382.0K
26.4K
Earning Date
05-11-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
91.75
N/A
EPS
N/A
N/A
Revenue
$13,107,000.00
N/A
Revenue This Year
$558.11
N/A
Revenue Next Year
$38.29
N/A
P/E Ratio
N/A
N/A
Revenue Growth
29.85
N/A
52 Week Low
$11.60
$2.80
52 Week High
$69.65
$4.45

Technical Indicators

Market Signals
Indicator
TNXP
MINE
Relative Strength Index (RSI) 43.00 39.20
Support Level $11.90 N/A
Resistance Level $14.52 $4.38
Average True Range (ATR) 0.76 0.18
MACD -0.05 -0.01
Stochastic Oscillator 22.75 5.36

Price Performance

Historical Comparison
TNXP
MINE

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a fully-integrated biopharmaceutical company commercializing and developing therapies for central nervous system (CNS) disorders, immunology, infectious diseases, and rare diseases. Its portfolio consists of commercial, development and discovery-stage programs, TONMYA, an approved treatment for fibromyalgia, as well as marketed acute migraine products Zembrace SymTouch and Tosymra. The company is conducting clinical trials to evaluate TONMYA for additional indications such as depressive disorder and acute stress disorder. It is also advancing a pipeline of immunology programs, including monoclonal antibody TNX-4800 for Lyme disease prophylaxis and TNX-1500, a third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection.

About MINE Mayfair Gold Corp. Common Shares

Mayfair Gold Corp is a mineral exploration company that is engaged in the acquisition and exploration of mineral properties. It has one material mineral property, the Fenn-Gib Gold Property, located in the Guibord, Munro, Michaud, and McCool Townships in northeast Ontario, which is in the exploration stage.

Share on Social Networks: